Roxybond Tablet, Coated
Product Images NDC 81140-102

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Roxybond (NDC 81140-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Protega Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Rox02 0001 01)

This is a line graph depicting drug liking measured by a Visual Analog Scale (VAS) over 24 hours. It compares responses for crushed intranasal oxycodone immediate-release tablets, crushed intranasal RoxyBond, intact oral RoxyBond, and placebo. The x-axis represents time in hours, and the y-axis shows drug liking VAS in millimeters.*

FDA Label Image

Structural Formula (Rox02 0001 02)

Chemical structure of oxycodone hydrochloride, showing its molecular arrangement including aromatic ring and functional groups. The molecular formula C18H21NO4·HCl and molecular weight 351.82 are noted in the image.*

FDA Label Image

Figure 2 (Rox02 0001 03)

A pharmacokinetic concentration-time graph showing plasma concentration (ng/mL) of oxycodone from RoxyBond tablets at dosages of 5 mg, 15 mg, and 30 mg over a 24-hour period. The graph illustrates peak concentration times and decline curves for each strength after oral administration.*

FDA Label Image

Principal Display Panel – 5 mg Bottle Label (Rox02 0001 04)

RoxyBond 5 mg coated tablets label with oxycodone hydrochloride as the active ingredient. The image shows a 100 tablet carton label by Protega Pharmaceuticals Inc, including storage information, dispenser attention notice, and tablet identification marks. The label states Rx Only and includes the NDC 81140-101-10.*

FDA Label Image

Principal Display Panel – 15 mg Bottle Label (Rox02 0001 05)

RoxyBond 15 mg coated tablets label containing oxycodone hydrochloride, manufactured by Protega Pharmaceuticals Inc. The label states the strength (15 mg), quantity (100 tablets), and includes storage instructions, dispensing warnings, and tablet identification markings on two sides. The product is labeled Rx only for oral use.*

FDA Label Image

Principal Display Panel – 30 mg Bottle Label (Rox02 0001 06)

Packaging label for RoxyBond 30 mg coated tablets containing oxycodone hydrochloride. The label indicates a bottle of 100 tablets, prescription use only, manufactured by Protega Pharmaceuticals Inc. It includes storage instructions, tablet identification marks (IDT/0 30), and a dispenser note about providing a medication guide with dispensing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.